NCT06934109
- Conditions
- Communication Disorders, Hemic and Lymphatic Diseases, Immune System Diseases, +25 more
- Locations
-
- Nottinghamshire Healthcare NHS Foundation Trust Nottingham, United Kingdom
Clinical trial condition
Immunoproliferative Disorders
Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.
10,009 public trials
2,034 recruiting studies
Immunoproliferative Disorders trial results
NCT05818423
- Conditions
- Cognition Disorders, Cognitive Decline, Cognitive Deficits, Mild, +16 more
- Locations
-
- University of California, San Francisco San Francisco, California, United States
NCT02315612
- Conditions
- ALL, Acute Lymphoblastic Leukemia, Acute Lymphocytic Leukemia, +32 more
- Locations
-
- National Institutes of Health Clinical Center Bethesda, Maryland, United States
Completed
Trial of the Combination of Bortezomib and Clofarabine in Adults With Relapsed Solid Tumors
NCT02211755
- Conditions
- Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
- Locations
-
- National Institutes of Health Clinical Center Bethesda, Maryland, United States
NCT04981795
- Conditions
- Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
- Alabama Oncology Birmingham, Alabama, United States
- Clearview Cancer Institute Huntsville, Alabama, United States
- University of California, Irvine Medical Center Orange, California, United States
- McFarland Clinic P.C. Ames, Iowa, United States
NCT05388123
- Conditions
- Hairy Cell Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +8 more
- Locations
-
- Scripps Cancer Center La Jolla, California, United States
NCT02783625
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
- Locations
-
- Stanford University Medical Center Stanford, California, United States
- Dana Farber Cancer Institute Boston, Massachusetts, United States
- University of Washington School of Medicine in St. Louis St Louis, Missouri, United States
- Washington University School of Medicine St Louis, Missouri, United States
NCT02661542
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
- Locations
-
- Sarah Cannon Research Institute at HealthOne Denver, Colorado, United States
- University of Texas MD Anderson Cancer Center Houston, Texas, United States
Completed
A Study to Evaluate 3 Dose Schedules of Daratumumab in Participants With Smoldering Multiple Myeloma
NCT02316106
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +15 more
- Locations
-
- Little Rock, Arkansas, United States
- Jacksonville, Florida, United States
- West Palm Beach, Florida, United States
- Atlanta, Georgia, United States
NCT03593018
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoblastic Lymphadenopathy, +6 more
- Locations
-
- University Hospital for Internal Medicine - University Hospital Graz Graz, Austria
- Medical University of Vienna Vienna, Austria
- A. Z. Sint-Jan Brugge-Oostende AV Bruges, Belgium
- Cliniques Universitaires de Bruxelles - Hôpital Erasme Brussels, Belgium